We are live on
!
Find out more
PCM
Pentwater Capital Management Portfolio holdings
AUM
$19.3B
1-Year Est. Return
58.13%
This Fund
S&P 500
This Quarter
Est. Return
+14.57%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$10.5B
AUM Growth
+$2.2B
(+27%)
Cap. Flow
+$1.93B
Cap. Flow
% of AUM
18.42%
Top 10 Holdings %
Top 10 Hldgs %
53.77%
Holding
422
New
188
Increased
50
Reduced
56
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$395M |
| 2 |
COHR
Coherent Inc
COHR
|
+$266M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$242M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$216M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$704M |
| 2 |
DuPont de Nemours
DD
|
+$162M |
| 3 |
International Flavors & Fragrances
IFF
|
+$92M |
| 4 |
EV
Eaton Vance Corp.
EV
|
+$91.7M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.95% |
| 2 | Technology | 13.98% |
| 3 | Communication Services | 6% |
| 4 | Industrials | 4.33% |
| 5 | Materials | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
TELA Bio
TELA
$38.9M
| $4.1M | 0.04% |
275,000
-6,864
| -2% | -$103K |
|
127
Gaotu Techedu
GOTU
$436M
| $4.07M | 0.04% |
+120,000
| New | +$9.77M |
|
128
Dropbox
DBX
$8.12B
| $3.87M | 0.04% |
145,000
+5,000
| +4% | +$120K |
|
129
Americold
COLD
$4.27B
| $3.85M | 0.04% |
100,000
| – | – |
|
130
Schrodinger
SDGR
$1.36B
| $3.81M | 0.04% |
50,000
-9,500
| -16% | -$854K |
|
131
Williams Companies
WMB
$86.1B
| $3.79M | 0.04% |
160,000
| – | – |
|
|
PPD
132
DELISTED
PPD, Inc. Common Stock
PPD
| $3.78M | 0.04% |
100,000
-15,000
| -13% | -$538K |
|
133
PUT
CrowdStrike
CRWD
$218B
| $3.65M | 0.03% |
+80,000
| New | +$4.23M |
|
134
Genworth Financial
GNW
$3.71B
| $3.59M | 0.03% |
1,080,000
-5,320,700
| -83% | -$17.5M |
|
135
CALL
Darden Restaurants
DRI
$24.4B
| $3.55M | 0.03% |
25,000
-70,000
| -74% | -$9.21M |
|
136
CALL
American Airlines Group
AAL
$10.6B
| $3.49M | 0.03% |
146,000
+126,000
| +630% | +$2.43M |
|
|
137
PUT
Genworth Financial
GNW
$3.71B
| $3.38M | 0.03% |
1,017,700
+767,700
| +307% | +$2.53M |
|
|
AZEK
138
PUT
DELISTED
The AZEK Co
AZEK
| $3.36M | 0.03% |
+80,000
| New | +$3.42M |
|
139
Alexandria Real Estate Equities
ARE
$8.56B
| $3.28M | 0.03% |
+19,983
| New | +$3.33M |
|
|
AEGN
140
DELISTED
Aegion Corp
AEGN
| $3.27M | 0.03% |
+113,850
| New | +$2.72M |
|
141
Warner Bros
WBD
$67.1B
| $3.22M | 0.03% |
+74,000
| New | +$3.69M |
|
|
GAPA.U
142
DELISTED
G&P Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
GAPA.U
| $3.2M | 0.03% |
+323,000
| New | +$3.2M |
|
143
Certara
CERT
$1.25B
| $3.19M | 0.03% |
116,900
+94,400
| +420% | +$3.14M |
|
|
ACCD
144
DELISTED
Accolade Inc
ACCD
| $3.18M | 0.03% |
70,000
+30,000
| +75% | +$1.44M |
|
145
CALL
Duke Energy
DUK
$97.3B
| $3.09M | 0.03% |
32,000
-39,000
| -55% | -$3.56M |
|
146
Regeneron Pharmaceuticals
REGN
$80.8B
| $3.08M | 0.03% |
6,500
| – | – |
|
147
PUT
PG&E
PCG
$38.5B
| $3.04M | 0.03% |
260,000
-877,100
| -77% | -$10.2M |
|
|
EBACU
148
DELISTED
European Biotech Acquisition Corp. Units
EBACU
| $3.02M | 0.03% |
+300,000
| New | +$3M |
|
|
RNLX
149
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $3.02M | 0.03% |
117,500
-36,000
| -23% | -$902K |
|
|
RYM
150
RYTHM Inc
RYM
$49M
| $2.96M | 0.03% |
+79
| New | +$3.27M |
|
Similar funds
CS
A
LF
MIM
SPIA
BPA
NAM
Pentwater Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Pentwater Capital Management held 422 positions worth $10.5B, up 27% from $8.28B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Pentwater Capital Management deployed $1.93B of net new capital in Q1 2021, opening 188 new positions and adding to 50 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 2,102,104 shares worth $456M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 7.5% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $162M trimmed.
- Pentwater Capital Management's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 2,102,104 shares worth $456M.
- Pentwater Capital Management added most to Xilinx Inc in Q1 2021, an estimated $242M increase.
- Pentwater Capital Management's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $162M.
- Pentwater Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $704M.
- Pentwater Capital Management's ten largest holdings make up 54% of its $10.5B portfolio in Q1 2021.
- Pentwater Capital Management opened 188 new positions and closed 85 in Q1 2021.
- Pentwater Capital Management's portfolio value rose 27% quarter-over-quarter to $10.5B.
Based on Pentwater Capital Management's 13F filing for Q1 2021, filed 17 May 2021.